• Home
  • A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative).

A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative).

Author List
Rugo HS, Schmid P, Tolaney SM, Marmé F, Bardia A, Spears PA, Cortés J
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/613164215
Publication Year
2025
PubMed ID
40045471
Publication Title
Rugo HS, Schmid P, Tolaney SM, Marmé F, Bardia A, Spears PA, Cortés J. A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative). Future Oncol. 2025 Mar; 21(7):775-786.